ShiraTronics
BROOKLYN CENTER, MN · Biotechnology · 50 employees
ShiraTronics is working to develop new innovative therapies to combat debilitating chronic migraine headache. We are focused on commercializing novel neuromodulation technologies for this large unmet clinical need.
Funding history
- Funding Round — $41.7M — Sep 2024
- Funding Round — $41.7M — Aug 2023
- Funding Round — $14.9M — Mar 2020
- Funding Round — $13.7M — Nov 2019
Recent signals
- Sep 30, 2024: Raised $41.7M
- Aug 11, 2023: Raised $41.7M
- Mar 27, 2020: Raised $14.9M
- Nov 05, 2019: Raised $13.7M
See plans & pricing → Track ShiraTronics’s funding, hiring, and signals — with verified contacts — on Fundz.